Research Update: Tackling Schizophrenia’s Most Debilitating Symptoms
Lundbeck's Dr. Bruce Kinon on the challenges related to treating negative symptoms of schizophrenia and new directions in negative-symptom research.

ABOUT THE NEWSROOM

Here you will find media contacts, plus the latest news, stories and insights from Lundbeck US. Lundbeck is a global pharmaceutical company solely focused on the brain, and our 900+ U.S. employees are committed to improving the lives of people affected by psychiatric and neurological disorders.